News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,190 Results
Type
Article (59149)
Company Profile (416)
Press Release (656625)
Multimedia
Podcasts (102)
Webinars (13)
Section
Business (192844)
Career Advice (3493)
Deals (35081)
Drug Delivery (118)
Drug Development (84492)
Employer Resources (179)
FDA (17310)
Job Trends (15251)
News (339623)
Policy (34352)
Tag
Academia (2888)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (93)
Alliances (50664)
ALS (98)
Alzheimer's disease (1489)
Antibody-drug conjugate (ADC) (150)
Approvals (17275)
Artificial intelligence (289)
Autoimmune disease (28)
Automation (16)
Bankruptcy (358)
Best Places to Work (12034)
BIOSECURE Act (21)
Biosimilars (114)
Biotechnology (318)
Bladder cancer (84)
Brain cancer (32)
Breast cancer (296)
Cancer (2403)
Cardiovascular disease (200)
Career advice (2959)
Career pathing (34)
CAR-T (173)
Cell therapy (485)
Cervical cancer (20)
Clinical research (68416)
Collaboration (900)
Company closure (1)
Compensation (538)
Complete response letters (28)
COVID-19 (2760)
CRISPR (48)
C-suite (258)
Cystic fibrosis (107)
Data (2258)
Decentralized trials (2)
Denatured (34)
Depression (53)
Diabetes (289)
Diagnostics (6472)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (43)
Drug discovery (134)
Drug pricing (118)
Drug shortages (32)
Duchenne muscular dystrophy (101)
Earnings (74234)
Editorial (45)
Employer branding (23)
Employer resources (155)
Events (114027)
Executive appointments (762)
FDA (18610)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (803)
Gene editing (118)
Generative AI (28)
Gene therapy (356)
GLP-1 (815)
Government (4863)
Grass and pollen (6)
Guidances (66)
Healthcare (19817)
Huntington's disease (24)
IgA nephropathy (30)
Immunology and inflammation (140)
Indications (30)
Infectious disease (2916)
Inflammatory bowel disease (151)
Inflation Reduction Act (11)
Influenza (55)
Intellectual property (101)
Interviews (687)
IPO (16395)
IRA (46)
Job creations (3683)
Job search strategy (2408)
Kidney cancer (11)
Labor market (36)
Layoffs (506)
Leadership (24)
Legal (7794)
Liver cancer (81)
Lung cancer (338)
Lymphoma (159)
Machine learning (7)
Management (62)
Manufacturing (333)
MASH (75)
Medical device (13574)
Medtech (13578)
Mergers & acquisitions (19256)
Metabolic disorders (765)
Multiple sclerosis (86)
NASH (23)
Neurodegenerative disease (112)
Neuropsychiatric disorders (34)
Neuroscience (2085)
NextGen: Class of 2025 (7104)
Non-profit (4862)
Now hiring (31)
Obesity (412)
Opinion (273)
Ovarian cancer (77)
Pain (99)
Pancreatic cancer (85)
Parkinson's disease (159)
Partnered (22)
Patents (244)
Patient recruitment (116)
Peanut (50)
People (56500)
Pharmaceutical (83)
Pharmacy benefit managers (20)
Phase I (21323)
Phase II (30064)
Phase III (22554)
Pipeline (1243)
Policy (159)
Postmarket research (2672)
Preclinical (9218)
Press Release (66)
Prostate cancer (113)
Psychedelics (37)
Radiopharmaceuticals (268)
Rare diseases (429)
Real estate (5892)
Recruiting (72)
Regulatory (23952)
Reports (37)
Research institute (2566)
Resumes & cover letters (565)
Rett syndrome (5)
RNA editing (5)
RSV (46)
Schizophrenia (80)
Series A (141)
Series B (91)
Service/supplier (11)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (164)
Sponsored (34)
Startups (3663)
State (2)
Stomach cancer (16)
Supply chain (70)
Tariffs (43)
The Weekly (66)
Vaccines (773)
Venture capitalists (42)
Weight loss (286)
Women's health (36)
Worklife (20)
Date
Today (147)
Last 7 days (930)
Last 30 days (2714)
Last 365 days (34335)
2025 (11316)
2024 (36672)
2023 (41157)
2022 (52331)
2021 (56963)
2020 (55557)
2019 (48730)
2018 (36962)
2017 (34181)
2016 (33979)
2015 (39098)
2014 (31836)
2013 (27111)
2012 (28648)
2011 (29204)
2010 (27608)
Location
Africa (988)
Alabama (55)
Alaska (7)
Arizona (202)
Arkansas (14)
Asia (42572)
Australia (7348)
California (6254)
Canada (2026)
China (550)
Colorado (271)
Connecticut (296)
Delaware (150)
Europe (97207)
Florida (920)
Georgia (206)
Idaho (61)
Illinois (590)
India (28)
Indiana (307)
Iowa (12)
Japan (166)
Kansas (106)
Kentucky (26)
Louisiana (12)
Maine (62)
Maryland (919)
Massachusetts (4818)
Michigan (227)
Minnesota (394)
Mississippi (2)
Missouri (91)
Montana (30)
Nebraska (26)
Nevada (64)
New Hampshire (68)
New Jersey (1769)
New Mexico (30)
New York (1785)
North Carolina (1048)
North Dakota (9)
Northern California (2707)
Ohio (213)
Oklahoma (14)
Oregon (37)
Pennsylvania (1395)
Puerto Rico (13)
Rhode Island (32)
South America (1335)
South Carolina (23)
South Dakota (1)
Southern California (2343)
Tennessee (98)
Texas (922)
United States (23848)
Utah (179)
Virginia (151)
Washington D.C. (63)
Washington State (578)
West Virginia (3)
Wisconsin (64)
716,190 Results for "susan g komen for the cure".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Columbus Rallies to Fund Life-Saving Research and Patient Care Services at Susan G. Komen® 2025 Race for the Cure
April 3, 2025
·
3 min read
Press Releases
New Report Confirms Racial Disparities in Breast Cancer Mortality: Susan G. Komen® Calls for Urgent Action to Close the Gap
February 20, 2025
·
3 min read
Lone Star Bio
Susan G. Komen® Announces More Than $10M in Grants Advancing Metastatic Breast Cancer Treatment and Precision Medicine
Susan G. Komen®, the world’s leading breast cancer organization, announced $10.05 million in research grants that aim to improve patient lives through better treatments for metastatic disease and advancements in precision medicine.
June 25, 2024
·
6 min read
Business
Susan G. Komen® Strengthens Leadership with Strategic Appointments to Board of Directors
Susan G. Komen®, the world’s leading breast cancer organization, announced four new global leaders to serve on its Board of Directors.
March 20, 2024
·
4 min read
Press Releases
Susan G. Komen® Honors Five Exceptional Leaders Who Have Transformed Breast Cancer Research and Patient Care
December 11, 2024
·
7 min read
BioMidwest
Susan G. Komen® and Walgreens Mark 5 Years of Impact, Surpassing $37 Million in Cancer Support
Susan G. Komen®, the world’s leading breast cancer organization and Walgreens announced another milestone in the transformative five-year collaboration that has not only propelled groundbreaking research in breast cancer but has also significantly expanded access to essential breast health and breast cancer services, support and resources.
March 25, 2024
·
3 min read
Lone Star Bio
Removing Barriers: Susan G. Komen® Launches Stand for H.E.R - A Health Equity Revolution Impact Report
Susan G. Komen®, the world’s leading breast cancer organization, has launched the Stand for H.E.R. – A Health Equity Revolution Breast Cancer Impact Report.
January 30, 2024
·
5 min read
Business
Susan G. Komen® Welcomes Nine Leaders to Research Advisory Roles
Susan G. Komen®, the world’s leading breast cancer organization, has appointed nine world-renowned medical and research experts to serve as advisors to the organization.
April 27, 2023
·
4 min read
Lone Star Bio
Susan G. Komen® Announces 2023 Grants to Accelerate Research Discoveries and Improve Outcomes for Breast Cancer Patients
Susan G. Komen ® , the world’s leading breast cancer organization, today announced the awarding of 49 new grants to researchers at 28 leading institutions in the U.S.
June 28, 2023
·
4 min read
Lone Star Bio
Susan G. Komen® Race for the Cure Raises Money for Cutting-Edge Breast Cancer Research
Susan G. Komen®, the world’s leading breast cancer organization, will hold an in-person Race for the Cure to raise critical funds that support breast cancer patients and advance research that brings us closer to the cures.
September 1, 2022
·
2 min read
1 of 71,619
Next